Document is current
Any future updates will be listed below
-
Authors
Tschandl, Philipp https://orcid.org/0000-0003-0391-7810
Rinner, Christoph https://orcid.org/0000-0002-3847-5664
Apalla, Zoe
Argenziano, Giuseppe https://orcid.org/0000-0003-1413-8214
Codella, Noel
Halpern, Allan
Janda, Monika
Lallas, Aimilios
Longo, Caterina
Malvehy, Josep
Paoli, John
Puig, Susana
Rosendahl, Cliff
Soyer, H. Peter https://orcid.org/0000-0002-4770-561X
Zalaudek, Iris
Kittler, Harald https://orcid.org/0000-0002-0051-8016
- License Information
-
More Information
Article History
Received: 26 September 2019
Accepted: 15 May 2020
First Online: 22 June 2020
Competing interests
: The authors declare the following competing interests: P.T. received fees from Silverchair and an unrestricted 1-year postdoc grant from MetaOptima Technology. N.C. is an IBM employee and owns diverse investments across technology and health-care companies. A.H. is a consultant to Canfield Scientific and an advisory board member of Scibase. M.J. is funded by a National Health and Medical Research Council (NHMRC) TRIP Fellowship (APP1151021). H.P.S. is a shareholder of MoleMap and e-derm-consult and undertakes regular teledermatological reporting for both companies, is a medical consultant for Canfield Scientific and Revenio Research Oy and a medical advisor for First Derm and MetaOptima Technology, and has a Medical Advisory Board Appointment with MoleMap. H.P.S. holds an Australian NHMRC Practitioner Fellowship (APP1137127). All other authors report no conflict of interest in the topic of this manuscript. This project was conducted after ethical committee review at the Medical University of Vienna under protocol numbers 1804/2017, 1503/2018 and 2308/2019. All participants of the study platform agreed to academic research of usage data upon registration and have continuous ability to withdraw that consent.
